Established under the National Blood Authority Act 2003, the National Blood Authority (NBA) Board provides advice to the General Manager about the performance of the NBA's functions. The Board is not a decision making body and has no formal or direct role in the governance or management of the NBA. The Board does however, consider key strategic issues facing the NBA.
The NBA Board’s roles and responsibilities fall into three main categories:
- Providing strategic direction;
- Helping to ensure effective governance, including the provision of advice on fraud, audit and risk management and the monitoring of the NBA’s financial reporting; and
- Liaising with stakeholders to strengthen relationships, promote the role of the NBA and contribute to the development of the organisation in a manner that furthers stakeholders’ requirements.
The Board is appointed by the Australian Government Minister for Health for a four-year term, based on nominees selected by the Council of Australian Governments (COAG) Health Council (former Standing Council on Health (SCoH)). The Board is required to consist of:
- A Chair;
- A person representing the interests of the Commonwealth;
- 1 or 2 persons representing the interests of the States and Territories;
- A person representing the community
- A person with expertise in public health issues relating to human blood; and
- A person with financial or commercial expertise.
Further information is available from the NBA Board Secretariat by email (board [at] blood.gov.au) or by telephone (02 6151 5066).
Current Board Members
Ms Gayle Ginnane - chair
Ms Gayle Ginnane was CEO of the Private Health Insurance Administration Council, a government agency reporting to the Minister for Health and Ageing, with financial and regulatory responsibility for the private health insurance industry until May 2008 and has broad experience as a senior manager in an insurance and regulatory environment, and an in depth understanding of governance, risk management and finance.
Ms Ginnane has considerable experience as an independent director on a number of boards, both commercial and not for profit, in the voluntary, government and private sectors. As well as Chair of the NBA Board, Ms Ginnane is a councillor on the Australian Pharmacy Council and a director of Police Health. She has also contributed to a number of voluntary organisations at senior and Board levels including Scouts ACT, the Arthur Shakespeare Foundation for Scouting and the Community Living Project.
Ms Ginnane is a member of the Institute of Public Administration, a fellow of the Australian Institute of Company Directors and an affiliate member of the Institute of Actuaries of Australia.
Ms Ginnane was appointed Chair of the NBA Board in May 2011.
Adjunct Professor Chris Brook – State/Territory representative (large jurisdiction)
Professor Chris Brook is currently the Chief Advisor Innovation, Safety and Quality for the Department of Health and Human Services (DHHS), Victoria.
This role is flexible and relates to in depth analysis and thinking about major policy issues, separate from day-to-day operations. Examples include Clinical Trials, Quality and Safety, Innovation and Transformation approaches to improve services to all Victorians.
As a personal appointment, he is also the State Health and Medical Commander (Emergency Management). This position provides command and coordination across the whole of DHHS services, encompassing all hospitals; ambulances; and others when a large scale emergency
He sits on the Clinical Trials Advisory Committee auspiced by the Commonwealth Department of Industry; and sits on the Advisory Board of the National Blood Authority, the Advisory Board of the Australian Commission on Safety and Quality in Health Care and the Board of the Centre for Evidence in Intervention and Preventive Science. He Chairs the Advisory Board of the Deakin School of Medicine.
Professor Brook was appointed to the NBA Board in May 2011.
State/Territory representative (small jurisdiction)
This position is currently vacant.
Mr Mark Cormack – Australian Government representative
Mr Mark Cormack is responsible for strategic national health policy, portfolio strategies and international engagement at the Department of Health. His National Programme responsibilities include Primary Health, Mental Health, Public Hospital Funding agreements and dental.
Prior to joining the department in February 2015 Mark was Deputy Secretary of the Immigration Status Resolution Group (ISRG) in the Department of Immigration and Border Protection (DIBP) from August 2013 – January 2015. ISRG is responsible for managing and resolving the immigration status of people who do not have legal authority to be in Australia or who are in breach of their visa conditions. The group is also responsible for the onshore detention network, community detention, bridging visa programmes, and the department’s compliance and removals functions. In addition, the group works with other countries to implement offshore processing and refugee settlement. Mark was the Department’s senior executive responsible for implementation of Operation Sovereign Borders.
Prior to joining DIBP, Mark was appointed the first Chief Executive Officer of Health Workforce Australia (HWA) in January 2010. HWA was a Commonwealth Statutory Authority, established by the Council of Australian Governments (COAG) which planned, funded, researched and delivered programmes to enhance and develop Australia’s health workforce.
From July 2006 to January 2010 Mark was Chief Executive of ACT Health.
Mark has had a number of senior roles in the public healthcare system, including Member, Australian Health Ministers’ Advisory Council (AHMAC); Chair, AHMAC Health Policy Priorities Principal Committee; and Board director, National E Health Transition Authority.
Mark has worked in and for the public healthcare sector for over 30 years in various capacities as a health professional, senior manager, policy maker, planner, agency head and industry advocate. He has a Bachelor of Applied Science (University of Sydney) and Master of Health Management (University of Wollongong).
He was appointed to the NBA Board in July 2015.
Mr Paul Bedbrook – Financial expert
Mr Paul Bedbrook has had a connection with blood issues via his personal involvement with haemophilia for over two decades. He is the father of two adult sons with haemophilia. For much of those two decades Mr Bedbrook has been involved with the Haemophilia Foundation NSW (HFNSW) and the Haemophilia Foundation Australia (HFA). He is a past President of HFNSW and past Treasurer of HFA. He brings his personal experiences with blood issues to the Board as well as feedback from a community of individuals who rely on the blood and plasma products distributed to Australia's health services under the auspices of the NBA.
Professionally, Mr Bedbrook has over 30 years of experience in financial services. He was a senior executive for over 20 years with the Dutch global banking, insurance and investment group, ING. His early career was as an investment analyst and investment portfolio manager and he was the General Manager Investments and Chief Investment Officer for the Mercantile Mutual (ING) Group in Sydney from 1987 to 1995. In the decade to 2010, he was President and CEO, INGDIRECT, Canada; CEO and director of ING Australia and Regional CEO, ING Asia Pacific based in Hong Kong. His current roles include: Chairman of Zurich Financial Services Australia Ltd, Independent non-executive Director of Credit Union Australia (CUA) Ltd, Independent Chairman of ASX listed Elanor Investors Group and Chairman of Disability Sports Australia.
Mr Bedbrook was appointed community representative on the NBA Board from May 2011 to August 2013. Mr Bedbrook was appointed financial expert on the NBA Board in August 2013 and is a member of the NBA Audit Committee.
Professor George Rubin – Public health expert
Professor George Rubin is an associate medical director in South Eastern Sydney Health District and a professor of public health at the Universities of Sydney and NSW. In the past he was President of the Australasian Faculty of Public Health Medicine; chaired the Australian Technical Advisory Group on Immunization; and, served as director of Epidemiology and then Chief Health Officer for NSW Health. He has worked as a medical epidemiologist with the US Centers for Disease Control in Atlanta, USA and in Bangladesh. He has published more than 150 scientific papers and works clinically as an addiction medicine specialist.
Professor Rubin was appointed to the NBA Board in May 2011. Mark Cormack joined the Department of Health in February 2015 as Deputy Secretary, Strategic Policy and Innovation Group (SPIG).
Ms Patricia Warn – Community representative
Trained originally as a secondary school teacher in Tasmania, Ms Warn was a social and political researcher for the ABC's Four Corners programme in Sydney for several years before becoming a Ministerial Advisor in Canberra across social security, health, community services and immigration. She organised national community consultations to inform policy development in reforming disability services, women's health, HIV/AIDS, Creutzfeldt–Jakob disease awareness and aged care.
Ms Warn was a member of the Commonwealth Immigration Review Tribunal for five years.
In retirement Ms Warn was appointed to the NSW Ministerial Advisory Committee on Ageing and became an Official Visitor to mental health facilities under the NSW Mental Health Act. She served for seven years as a Board member of Uniting Care Ageing's Sydney region and remains on its Advisory Council.
Ms Warn has been a lay member of the NSW Law Society's Professional Conduct Committee for a decade and has represented consumer interests on committees of the Australian Commission on Safety and Quality in Health Care, Health Workforce Australia, the Australian Council on Health Care Standards and the Australian Health Practitioner Registration Agency. She is on the Board of the Aged Rights Service (TARS) in Sydney.
Ms Warn's personal commitment to the NBA stems from her mother's life being saved by blood transfusions following a postpartum haemorrhage 60 years ago.
Ms Warn was appointed to the NBA Board as the community representative in August 2013.